To confirm this differential expression and to assess the clinical significance of TRIB3 in this oncogenic setting, the TCGA dataset was analyzed to evaluate TRIB3 levels in 530 RCC tumor tissue samples and 72 paracancerous samples. This evidence concerns the gene TRIB3 and renal cell carcinoma.